-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target

Benzinga·06/20/2025 15:42:37
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $31 price target.